Lerodalcibep can be a treatment option for patients requiring additional LDL-C reduction: GlobalData GlobalData Mar 4, 2025 Lerodalcibep is a novel therapy designed to lower low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic…
US FDA approves Repatha to treat certain patients with high cholesterol Usha Sharma Aug 28, 2015 The most common side effects of Repatha include nasopharyngitis, upper respiratory tract infection, flu, back pain, and reactions…
